These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15723282)

  • 1. Tuning the polymer release from hydrophilic matrix tablets by mixing short and long matrix polymers.
    Körner A; Larsson A; Piculell L; Wittgren B
    J Pharm Sci; 2005 Apr; 94(4):759-69. PubMed ID: 15723282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities.
    Körner A; Larsson A; Andersson A; Piculell L
    J Pharm Sci; 2010 Mar; 99(3):1225-38. PubMed ID: 19718760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular information on the dissolution of polydisperse polymers: Mixtures of long and short poly(ethylene oxide).
    Körner A; Larsson A; Piculell L; Wittgren B
    J Phys Chem B; 2005 Jun; 109(23):11530-7. PubMed ID: 16852413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of substitution pattern of HPMC on polymer release from matrix tablets.
    Viridén A; Larsson A; Wittgren B
    Int J Pharm; 2010 Apr; 389(1-2):147-56. PubMed ID: 20100556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).
    Abrahmsén-Alami S; Körner A; Nilsson I; Larsson A
    Int J Pharm; 2007 Sep; 342(1-2):105-14. PubMed ID: 17580107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between drug dissolution and polymer hydration: a study using texture analysis.
    Li H; Gu X
    Int J Pharm; 2007 Sep; 342(1-2):18-25. PubMed ID: 17548178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
    Lee KR; Kim EJ; Seo SW; Choi HK
    Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance.
    Kaialy W; Maniruzzaman M; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Dec; 477(1-2):282-93. PubMed ID: 25447824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF; Tang H; Guo H; Pan WS
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques.
    Leskinen JT; Hakulinen MA; Kuosmanen M; Ketolainen J; Abrahmsén-Alami S; Lappalainen R
    Int J Pharm; 2011 Feb; 404(1-2):142-7. PubMed ID: 21094229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
    Coutts-Lendon C; Koenig JL
    Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
    Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
    Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.